NEW YORK (GenomeWeb News) – Purdue University has received a $1 million grant from the W.M. Keck Foundation to develop technologies to alter epigenetic marks in the genome that turn genes on and off.

The research, the university said, may result in new ways of treating genetic diseases.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

An opinion piece in the Guardian argues that President Donald Trump is uninterested in science and that might not be a bad thing for the field.

The San Francisco Chronicle reports the Veterans Affairs Health System is studying whether genetic testing can help prescribe better depression therapies.

Stat News reports that Spark Therapeutics' Luxturna is now being used to treat a wider array of patients.

In Genome Biology this week: transcription factor use among brittle stars, single-cell RNA sequencing strategy, and more.